- Baxter International Inc (NYSE: BAX) has agreed to provide manufacturing services for Moderna Inc's (NASDAQ: MRNA) COVID-19 Vaccine.
- The agreement includes fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.
- Manufacturing facilities located in Bloomington, Indiana, will be used. It employs more than 700 individuals on its 600,000 square-foot campuses.
- Additional details of the agreement were not disclosed.
- Price Action: MRNA shares are trading lower at 1.54% at $130.24 on the last check Monday. BAX shares are up 0.37% at $78.35.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in